ROS and oncogenesis with special reference to EMT and stemness
Ritam Chatterjee1, Jyotirmoy Chatterjee1
1School of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur, West Bengal, 721302, India.
European Journal of Cell Biology
|March 24, 2020
Summary
Reactive oxygen species (ROS) play a dual role in cancer, influencing normal cell functions and causing oxidative stress. This review explores ROS
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Reactive oxygen species (ROS) are crucial for cellular signaling in redox biology.
- Elevated ROS levels cause oxidative stress, damaging cellular components and contributing to diseases like cancer.
- ROS act as a "double-edged sword" in oncogenesis, potentially suppressing or promoting tumor progression.
Purpose of the Study:
- To review the multifaceted roles of ROS in tumor biology.
- To highlight the involvement of ROS in epithelial-mesenchymal transition (EMT) and cancer stem cells.
Main Methods:
- Literature review of studies on ROS, oxidative stress, and cancer.
- Analysis of signaling pathways influenced by ROS in neoplasia.
Main Results:
- ROS can promote or suppress cancer progression depending on the signaling pathways involved.
- ROS contribute to phenotypic plasticity and the acquisition of stemness in cancer cells.
- The review synthesizes current understanding of ROS in EMT and cancer stem cell biology.
Conclusions:
- ROS are critical regulators in cancer development and progression.
- Targeting ROS pathways may offer therapeutic strategies for cancer treatment.
- Further research into ROS, EMT, and cancer stem cells is warranted.
Related Concept Videos
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Cancer Stem Cells and Tumor Maintenance
5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
mTOR Signaling and Cancer Progression
4.5K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.5K
Mitogens and the Cell Cycle
7.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.5K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.5K
Rous Sarcoma Virus (RSV) and Cancer
6.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.0K


